RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
WellBiotec Co Stock

WellBiotec Co Liabilities 2025

WellBiotec Co Liabilities

22.23 B KRW

Ticker

010600.KS

ISIN

KR7010600005

In 2025, WellBiotec Co's total liabilities amounted to 22.23 B KRW, a -9.31% difference from the 24.52 B KRW total liabilities in the previous year.

WellBiotec Co Aktienanalyse

What does WellBiotec Co do?

WellBiotec Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing WellBiotec Co's Liabilities

WellBiotec Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating WellBiotec Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing WellBiotec Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

WellBiotec Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in WellBiotec Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about WellBiotec Co stock

What is the level of liabilities of WellBiotec Co this year?

WellBiotec Co has a debt balance of 22.23 B KRW this year.

What were the liabilities of WellBiotec Co compared to the previous year?

The liabilities of WellBiotec Co have increased by -9.31% dropped compared to the previous year.

What are the consequences of high debt for investors of WellBiotec Co?

High liabilities can pose a risk for investors of WellBiotec Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in WellBiotec Co?

Low liabilities mean that WellBiotec Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of WellBiotec Co affect the company?

An increase in liabilities of WellBiotec Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of WellBiotec Co affect the company?

A decrease in the liabilities of WellBiotec Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of WellBiotec Co?

Some factors that can influence the liabilities of WellBiotec Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of WellBiotec Co so important for investors?

The liabilities of WellBiotec Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can WellBiotec Co take to modify the liabilities?

To change its liabilities, WellBiotec Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does WellBiotec Co pay?

Over the past 12 months, WellBiotec Co paid a dividend of 136.36 KRW . This corresponds to a dividend yield of about 25.02 %. For the coming 12 months, WellBiotec Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of WellBiotec Co?

The current dividend yield of WellBiotec Co is 25.02 %.

When does WellBiotec Co pay dividends?

WellBiotec Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of WellBiotec Co?

WellBiotec Co paid dividends every year for the past 0 years.

What is the dividend of WellBiotec Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is WellBiotec Co located?

WellBiotec Co is assigned to the 'Cyclical consumption' sector.

Wann musste ich die Aktien von WellBiotec Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of WellBiotec Co from 4/24/2006 amounting to 150 KRW, you needed to have the stock in your portfolio before the ex-date on 12/28/2005.

When did WellBiotec Co pay the last dividend?

The last dividend was paid out on 4/24/2006.

What was the dividend of WellBiotec Co in the year 2024?

In the year 2024, WellBiotec Co distributed 0 KRW as dividends.

In which currency does WellBiotec Co pay out the dividend?

The dividends of WellBiotec Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von WellBiotec Co

Our stock analysis for WellBiotec Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of WellBiotec Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.